Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Operating Cash Flow Growth
-15.28%
Quarterly · Period ending:
BIO Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-15.28%period ending
Latest reported-15.28%period ending
BIO Quarterly Cash from Operations YoY % (-25.00% → -15.28%)
Year-over-year change
High-resolution chart · PNG
BIO operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 95.5586% | |
| 138.0453% | |
| -73.3846% | |
| -34.6939% | |
| 52.0256% | |
| -515.8571% | |
| 93.8596% | |
| 15.2941% | |
| 56% | |
| 1,500% | |
| 147.8261% | |
| -14.1414% | |
| 2.7397% | |
| 85.7143% | |
| -45.8824% | |
| 607.1429% | |
| -51.0067% | |
| -108.3333% | |
| -42.953% | |
| -73.0769% | |
| 55.2083% | |
| -1.1765% | |
| 29.5652% | |
| -30.6667% | |
| -32.8671% | |
| -43.3333% | |
| -44.1748% | |
| 59.5745% | |
| 2,142.8571% | |
| 814.2857% | |
| 292.5234% | |
| -74.8663% | |
| 58.8235% | |
| 8.6957% | |
| -252.8571% | |
| 2,177.7778% | |
| -189.4737% | |
| 41.0256% | |
| 169.2308% | |
| -120% | |
| 216.6667% | |
| -188.6364% | |
| -29.7297% | |
| -25% |